Currently out of the existing stock ratings of Lisa Walter, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).

Lisa Walter

Work Performance Price Targets & Ratings Chart

Analyst Lisa Walter, currently employed at RBC, carries an average stock price target met ratio of 23.61% that have a potential upside of 20.18% achieved within 108 days.

Lisa Walter’s has documented 89 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on EYPT, Eyepoint Pharmaceuticals at 17-Aug-2026.

Wall Street Analyst Lisa Walter

Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) at 2/25/2026. The price target of $21 was fulfilled within 2 days with a profit of $0.42 (1.96%) receiving and performance score of 9.8.

Average potential price target upside

of $134.91 (30.47%) on UTHR (UNITED THERAPEUTICS).
of $3.16 (9.76%) on APLS (APELLIS PHARMACEUTICALS).
of $2.02 (67.79%) on ADVM (ADVERUM BIOTECHNOLOGIES).

ADVM Adverum Biotechnologies APLS Apellis Pharmaceuticals EYPT Eyepoint Pharmaceuticals FDMT 4D Molecular Therapeutics MGTX MeiraGTx Holdings PLC OCUL Ocular Therapeutix RYTM Rhythm Pharmaceuticals UTHR United Therapeutics VRDN Viridian Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matthew Caufield (HC WAINWRIGHT)